(NIH/National Institute of Allergy and Infectious Diseases) An investigational oral antibiotic called zoliflodacin was well-tolerated and successfully cured most cases of uncomplicated gonorrhea when tested in a Phase 2 multicenter clinical trial, according to findings published today in the New England Journal of Medicine. The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health, sponsored the clinical study.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2ARGEqq
No comments:
Post a Comment